(Q43738534)

26 November 2017

title

Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study (English)

1 reference

26 November 2017

1 reference

Hojjat Ahmadzadehfar

1

0 references

author name string

Carsten Meyer

2

1 reference

26 November 2017

Samer Ezziddin

3

1 reference

26 November 2017

Amir Sabet

4

1 reference

26 November 2017

Anja Hoff-Meyer

5

1 reference

26 November 2017

Marianne Muckle

6

1 reference

26 November 2017

Timur Logvinski

7

1 reference

26 November 2017

Hans Heinz Schild

8

1 reference

26 November 2017

Hans Jürgen Biersack

9

1 reference

26 November 2017

Kai Wilhelm

10

1 reference

26 November 2017

publication date

13 October 2012

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

26 November 2017

published in

1 reference

26 November 2017

volume

40

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

80-90

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-012-2253-2

26 November 2017

exact match

0 references

cites work

Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Radioembolization of liver tumors with yttrium-90 microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with 90yttrium microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Portal vein embolization: what do we know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Trends in long-term survival following liver resection for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Resection of liver metastases from breast cancer: towards a management guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - an audit of 26 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Transarterial chemoembolization of liver metastases: Indication, technique, results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Liver Metastases: Neoadjuvant Downsizing with Transarterial Chemoembolization before Laser-Induced Thermotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Changes in liver and spleen volumes and liver function after radioembolization with yttrium-90 resin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2253-2

Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach

21 January 2018

1 reference

12 December 2020

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization

1 reference

12 December 2020

Is prophylactic embolization of the hepatic falciform artery needed before radioembolization in patients with 99mTc-MAA accumulation in the anterior abdominal wall?

1 reference

12 December 2020

Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization

1 reference

12 December 2020

Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance

1 reference

12 December 2020

Significance of oral administration of sodium perchlorate in planning liver-directed radioembolization

1 reference

12 December 2020

10.1007/S00259-012-2253-2

Identifiers

DOI

1 reference

26 November 2017

1 reference